VolitionRx Ltd Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Common Stock (Details Narrative)

Common Stock (Details Narrative) - USD ($)			1 Months Ended			7 Months Ended	9 Months Ended
Common Stock (Details Narrative) - USD ($)	Aug. 12, 2020	Sep. 07, 2018	Sep. 18, 2020	May 21, 2020	May 20, 2020	Aug. 17, 2020	Sep. 30, 2020	Sep. 30, 2019	Jan. 12, 2020	Dec. 31, 2019
Common stock, shares authorized							100,000,000			100,000,000
Common stock, shares issued							48,064,575			41,125,303
Common stock, shares outstanding							48,064,575			41,125,303
Common stock, par value							$ 0.001			$ 0.001
Common Stock Fair value							$ 48,065			$ 41,125
Net proceeds from isuance of common stock							19,200,954	$ 16,488,257
Chief Medical Officer [Member]
Common Stock Fair value									$ 54,434
Common stock, shares purchased									11,364
Common stock, purchase price									$ 4.79
Option Five [Member]
Net proceeds from isuance of common stock			$ 61,750
Common stock shares issuable upon exercise of warrants			25,000
Purchase price			$ 2.47
Option Four [Member]
Net proceeds from isuance of common stock	$ 45,000
Common stock shares issuable upon exercise of warrants	15,000
Purchase price	$ 3.00
Option Three [Member]
Net proceeds from isuance of common stock	$ 37,500
Common stock shares issuable upon exercise of warrants	15,000
Purchase price	$ 2.50
Option [Member]
Net proceeds from isuance of common stock						$ 30,033
Common stock shares issuable upon exercise of warrants						97,500
Purchase price						$ 2.50
Option [Member] \| From July 21, 2020 to August 12, 2020 [Member]
Net proceeds from isuance of common stock							$ 22,261
Common stock shares issuable upon exercise of warrants							210,000
Purchase price							$ 3.00
Option [Member] \| From July16, 2020 to August 10, 2020 [Member]
Net proceeds from isuance of common stock							$ 39,197
Common stock shares issuable upon exercise of warrants							210,000
Purchase price							$ 2.50
Option [Member] \| From February 24, 2020 to September 2, 2020 [Member]
Net proceeds from isuance of common stock							$ 2,752
Common stock shares issuable upon exercise of warrants							11,599
Purchase price							$ 2.35
Stock Option Two [Member] \| January 7, 2020 [Member]
Net proceeds from isuance of common stock							$ 6,486
Common stock shares issuable upon exercise of warrants							35,000
Purchase price							$ 4.00
Stock Option One [Member]
Net proceeds from isuance of common stock						$ 16,539
Common stock shares issuable upon exercise of warrants						97,500
Purchase price						$ 3.00
National Securities Corporation [Member]
Additional shares issued					654,750
Common stock price per share							2.75
Purchase price, public offering							$ 2.75
Stock issued during period, shares				5,000,000	4,365,000
Stock issued during period, Amount				$ 13,800,000
Legal fees				1,100,000
Net proceeds from isuance of common stock				$ 12,700,000
2015 Equity Incentive Plan [Member] \| Option [Member]
Common stock, shares authorized							6,500,000
Equity Distribution Agreement [Member]
Common stock, shares issued							1,688,555
Net proceeds from isuance of common stock		$ 10,000,000					$ 6,500,000
Agreement fees		$ 104,813					$ 104,813
Director [Member]
Common stock, shares issued							73,263
Common Stock Fair value							$ 333,969